A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network

Table 3

Breast cancer disease-specific pathways for each dataset.

	GSE15852	GSE20438	GSE2043	GSE2929	Integrated; pathways
# of pathways	109	7	17	21	143

Enriched pathways were identified by GSEA. For integration, the pathways with ( value < 0.01) were selected as significant pathways for each expression profile and their union was defined as “disease-specific pathways.”